Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer-related cells

Cancer Science

Volumn 101, Issue 6, 2010, Pages 1354-1360

  El Tanani, Mohamed K ^a   Yuen, Hiu Fung ^a   Shi, Zhanzhong ^a,b   Platt Higgins, Angela ^c   Buckley, Niamh E ^a   Mullan, Paul B ^a   Harkin, Denis Paul ^a   Johnston, Patrick G ^a   Rudland, Philip S ^c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b KINGSTON UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; OSTEOPONTIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; COMPARATIVE STUDY; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HUMANS; NEOPLASM INVASIVENESS; OSTEOPONTIN; RATS; RATS, WISTAR; TRANSFECTION;

EID: 77954172681     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01561.x     Document Type: Article

References (29)

1. Peto J, Collins N, Barfoot R. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 1999, 91:943-9.
2. Struewing JP, Tarone RE, Brody LC, Li FP, Boice JD. BRCA1 mutations in young women with breast cancer. Lancet 1996, 347:1493.
3. Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA, Holt JT. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J Biol Chem 1999, 274:18808-12.
4. Moynahan ME, Chiu JW, Koller BH, Jasin M. Brca1 controls homology-directed DNA repair. Mol Cell 1999, 4:511-8.
5. El-Tanani MK, Campbell FC, Crowe P. BRCA1 suppresses osteopontin-mediated breast cancer. J Biol Chem 2006, 281:26587-601.
6. El-Tanani MK. Role of osteopontin in cellular signaling and metastatic phenotype. Front Biosci 2008, 13:4276-84.
7. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993, 7:1475-82.
8. Oates AJ, Barraclough R, Rudland PS. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 1996, 13:97-104.
9. Tuck AB, Arsenault DM, O'Malley FP. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene 1999, 18:4237-46.
10. He B, Mirza M, Weber GF. An osteopontin splice variant induces anchorage independence in human breast cancer cells. Oncogene 2006, 25:2192-202.
11. Allan AL, George R, Vantyghem SA. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer. Am J Pathol 2006, 169:233-46.
12. Singhal H, Bautista DS, Tonkin KS. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res 1997, 3:605-11.
13. Rudland PS, Platt-Higgins A, El-Tanani M. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res 2002, 62:3417-27.
14. Bramwell VH, Doig GS, Tuck AB. Serial plasma osteopontin levels have prognostic value in metastatic breast cancer. Clin Cancer Res 2006, 12:3337-43.
15. Dunnington DJ, Hughes CM, Monaghan P, Rudland PS. Phenotypic instability of rat mammary tumor epithelial cells. J Natl Cancer Inst 1983, 71:1227-40.
16. Miki Y, Swensen J, Shattuck-Eidens D. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71.
17. Kurisetty VV, Johnston PG, Johnston N. RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin. Oncogene 2008, 27:7139-49.
18. Davies BR, Barraclough R, Rudland PS. Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines. Cancer Res 1994, 54:2785-93.
19. Jamieson S, Barraclough R, Rudland PS. Generation of metastatic variants by transfection of a nonmetastatic rat mammary epithelial cell line with DNA from a metastatic rat mammary cell line. Pathobiology 1990, 58:329-42.
20. Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD. MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 2007, 104:13-9.
21. Rae JM, Ramus SJ, Waltham M. Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin Exp Metastasis 2004, 21:543-52.
22. Zhang RD, Fidler IJ, Price JE. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 1991, 11:204-15.
23. Schiemann S, Schwirzke M, Brunner N, Weidle UH. Molecular analysis of two mammary carcinoma cell lines at the transcriptional level as a model system for progression of breast cancer. Clin Exp Metastasis 1998, 16:129-39.
24. Zhang J, Guo H, Mi Z. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells. Exp Cell Res 2009, 315:304-12.
25. Emani S, Zhang J, Guo L, Guo H, Kuo PC. RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer. Surgery 2008, 143:803-12.
26. El-Tanani M, Platt-Higgins A, Rudland PS, Campbell FC. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J Biol Chem 2004, 279:20794-806.
27. El-Tanani M, Fernig DG, Barraclough R, Green C, Rudland P. Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors. J Biol Chem 2001, 276:41675-82.
28. Couzin J. The twists and turns in BRCA's path. Science 2003, 302:591-3.
29. Ouchi T, Lee SW, Ouchi M, Aaronson SA, Horvath CM. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. Proc Natl Acad Sci USA 2000, 97:5208-13.